Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
LSTA
$1.15
+6.48%
LSTA · Lisata Therapeutics, Inc.
$1.15
+0.07 (+6.48%)
At close · Aug 18
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on its current business plan and current capital resources, combined with the need to raise additional funding and the uncertainty regarding the availability of such additional funding, management has concluded that there is substantial doubt regarding the Company's ability to continue as a going concern for a period of twelve months after the date these consolidated financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$9.73M
Shares
9.01M
All earnings calls
Earnings call · FY2024 Q4
Lisata Therapeutics, Inc. Q4 FY2024 Earnings Call
Lisata Therapeutics, Inc. Q4 FY2024 Earnings Call
Research coverage
3 live sources
Switch sources without leaving this page or losing your listening position.
Revenue · derived Q4
$1.00M
Net income · derived Q4
-$4.61M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Feb 27, 2025 · complete as-filed document
SEC periodic report
10-K report
Filed Feb 27, 2025 · complete as-filed document